Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU

What is it about?

Between 8 and 15% of the US population carries a penicillin allergy label, yet less than 5% of these can be verified by allergy testing. In a high acuity setting where antibiotic needs are considerable, we demonstrate that a risk-stratified approach to penicillin allergy evaluation and de-labeling is feasible, safe and effective. It’s predicted that systematic application of risk-stratified penicillin allergy management will reduce the prevalence of adverse outcomes associated with penicillin allergy labels.

Featured Image